These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 1549851

  • 1. Trimethoprim-sulfamethoxazole prophylaxis for Pneumocystis carinii infections in heart-lung and lung transplantation--how effective and for how long?
    Kramer MR, Stoehr C, Lewiston NJ, Starnes VA, Theodore J.
    Transplantation; 1992 Mar; 53(3):586-9. PubMed ID: 1549851
    [Abstract] [Full Text] [Related]

  • 2. Recurrent Pneumocystis carinii colonization in a heart-lung transplant recipient on long-term trimethoprim-sulfamethoxazole prophylaxis.
    Faul JL, Akindipe OA, Berry GJ, Doyle RL, Theodore J.
    J Heart Lung Transplant; 1999 Apr; 18(4):384-7. PubMed ID: 10226906
    [Abstract] [Full Text] [Related]

  • 3. Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past.
    Wang EH, Partovi N, Levy RD, Shapiro RJ, Yoshida EM, Greanya ED.
    Transpl Infect Dis; 2012 Oct; 14(5):519-25. PubMed ID: 22571389
    [Abstract] [Full Text] [Related]

  • 4. Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipients.
    Zmarlicka M, Martin ST, Cardwell SM, Nailor MD.
    Prog Transplant; 2015 Sep; 25(3):210-6. PubMed ID: 26308779
    [Abstract] [Full Text] [Related]

  • 5. Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation.
    Prasad GVR, Beckley J, Mathur M, Gunasekaran M, Nash MM, Rapi L, Huang M, Zaltzman JS.
    BMC Infect Dis; 2019 Apr 05; 19(1):311. PubMed ID: 30953458
    [Abstract] [Full Text] [Related]

  • 6. Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6-month trimethoprim-sulfamethoxazole prophylaxis: A case-control study.
    Park SY, Jung JH, Kwon H, Shin S, Kim YH, Chong YP, Lee SO, Choi SH, Kim YS, Woo JH, Kim SH, Han DJ.
    Transpl Infect Dis; 2020 Apr 05; 22(2):e13245. PubMed ID: 31943590
    [Abstract] [Full Text] [Related]

  • 7. Prevention of Pneumocystis carinii pneumonia in cardiac transplant recipients by trimethoprim sulfamethoxazole.
    Olsen SL, Renlund DG, O'Connell JB, Taylor DO, Lassetter JE, Eastburn TE, Hammond EH, Bristow MR.
    Transplantation; 1993 Aug 05; 56(2):359-62. PubMed ID: 8356591
    [Abstract] [Full Text] [Related]

  • 8. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
    Colby C, McAfee S, Sackstein R, Finkelstein D, Fishman J, Spitzer T.
    Bone Marrow Transplant; 1999 Oct 05; 24(8):897-902. PubMed ID: 10516703
    [Abstract] [Full Text] [Related]

  • 9. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole.
    Fisher RG, Nageswaran S, Valentine ME, McKinney RE.
    AIDS Patient Care STDS; 2001 May 05; 15(5):263-9. PubMed ID: 11530767
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Aerosolized pentamidine as alternative primary prophylaxis against Pneumocystis carinii pneumonia in adult hepatic and renal transplant recipients.
    Saukkonen K, Garland R, Koziel H.
    Chest; 1996 May 05; 109(5):1250-5. PubMed ID: 8625676
    [Abstract] [Full Text] [Related]

  • 12. Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis.
    de Boer MG, Kroon FP, le Cessie S, de Fijter JW, van Dissel JT.
    Transpl Infect Dis; 2011 Dec 05; 13(6):559-69. PubMed ID: 21689251
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids-clinical implication of primary prophylaxis using trimethoprim-sulfamethoxazole.
    Park JW, Curtis JR, Kim MJ, Lee H, Song YW, Lee EB.
    Arthritis Res Ther; 2019 Sep 14; 21(1):207. PubMed ID: 31521185
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Aerosolized pentamidine prophylaxis for Pneumocystis carinii pneumonia after allogeneic marrow transplantation.
    Marras TK, Sanders K, Lipton JH, Messner HA, Conly J, Chan CK.
    Transpl Infect Dis; 2002 Jun 14; 4(2):66-74. PubMed ID: 12220242
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of once-weekly dapsone dosing for Pneumocystis jirovecii pneumonia prophylaxis post transplantation.
    Evans RA, Clifford TM, Tang S, Au T, Fugit AM.
    Transpl Infect Dis; 2015 Dec 14; 17(6):816-21. PubMed ID: 26369753
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.